nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—AVPR1A—autistic disorder	0.872	1	CbGaD
Conivaptan—Tolvaptan—AVPR1A—autistic disorder	0.00499	1	CrCbGaD
Conivaptan—AVPR1A—central nervous system—autistic disorder	0.0009	0.183	CbGeAlD
Conivaptan—AVPR2—head—autistic disorder	0.000817	0.166	CbGeAlD
Conivaptan—AVPR2—nervous system—autistic disorder	0.000775	0.157	CbGeAlD
Conivaptan—AVPR2—central nervous system—autistic disorder	0.000746	0.151	CbGeAlD
Conivaptan—AVPR1A—brain—autistic disorder	0.000715	0.145	CbGeAlD
Conivaptan—AVPR2—brain—autistic disorder	0.000592	0.12	CbGeAlD
Conivaptan—CYP3A4—digestive system—autistic disorder	0.000153	0.0309	CbGeAlD
Conivaptan—AVPR2—GPCR downstream signaling—GABBR1—autistic disorder	0.000131	0.00111	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADM—autistic disorder	0.000131	0.00111	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GRM5—autistic disorder	0.00013	0.0011	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—VIP—autistic disorder	0.00013	0.0011	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR5A—autistic disorder	0.000129	0.00109	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PDE4B—autistic disorder	0.000128	0.00108	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR5A—autistic disorder	0.000128	0.00108	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PDE4B—autistic disorder	0.000127	0.00108	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—OXTR—autistic disorder	0.000126	0.00107	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—OXTR—autistic disorder	0.000126	0.00106	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—SCT—autistic disorder	0.000125	0.00106	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—SCT—autistic disorder	0.000124	0.00105	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—OPRM1—autistic disorder	0.000124	0.00105	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—OPRM1—autistic disorder	0.000123	0.00104	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GABBR1—autistic disorder	0.000119	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADM—autistic disorder	0.000119	0.00101	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADM—autistic disorder	0.000119	0.001	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GABBR1—autistic disorder	0.000119	0.001	CbGpPWpGaD
Conivaptan—CYP3A4—nervous system—autistic disorder	0.000118	0.0239	CbGeAlD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.000117	0.000987	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PDE4B—autistic disorder	0.000116	0.000985	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.000116	0.00098	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PDE4B—autistic disorder	0.000116	0.000978	CbGpPWpGaD
Conivaptan—CYP3A4—central nervous system—autistic disorder	0.000114	0.023	CbGeAlD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—autistic disorder	0.000113	0.00096	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—OPRM1—autistic disorder	0.000113	0.000954	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—OPRM1—autistic disorder	0.000112	0.000947	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HTR2A—autistic disorder	0.000111	0.000941	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR2A—autistic disorder	0.00011	0.000935	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—OXT—autistic disorder	0.00011	0.000933	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR1B—autistic disorder	0.00011	0.000933	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GABBR2—autistic disorder	0.000109	0.000927	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR1B—autistic disorder	0.000109	0.000926	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—OXT—autistic disorder	0.000109	0.000926	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GABBR2—autistic disorder	0.000109	0.00092	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—CYP19A1—autistic disorder	0.000105	0.000887	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—AVP—autistic disorder	0.000103	0.000869	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—DRD1—autistic disorder	0.000102	0.000867	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—DRD1—autistic disorder	0.000102	0.000861	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR1B—autistic disorder	0.0001	0.000847	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—OXT—autistic disorder	0.0001	0.000847	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR1B—autistic disorder	9.93e-05	0.000841	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—OXT—autistic disorder	9.93e-05	0.000841	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—DRD3—autistic disorder	9.92e-05	0.00084	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—DRD3—autistic disorder	9.85e-05	0.000834	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR1D—autistic disorder	9.76e-05	0.000826	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM5—autistic disorder	9.75e-05	0.000825	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IL5—autistic disorder	9.71e-05	0.000822	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR1D—autistic disorder	9.69e-05	0.00082	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL5—autistic disorder	9.64e-05	0.000816	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM5—autistic disorder	9.62e-05	0.000814	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CALCA—autistic disorder	9.59e-05	0.000812	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CALCA—autistic disorder	9.52e-05	0.000806	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—CAT—autistic disorder	9.44e-05	0.000799	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRLR—autistic disorder	9.39e-05	0.000795	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRLR—autistic disorder	9.32e-05	0.000789	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—DRD1—autistic disorder	9.3e-05	0.000787	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—DRD1—autistic disorder	9.24e-05	0.000782	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GRM8—autistic disorder	9.07e-05	0.000768	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—DRD3—autistic disorder	9.01e-05	0.000763	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GRM8—autistic disorder	9.01e-05	0.000762	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—DRD3—autistic disorder	8.95e-05	0.000757	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	8.91e-05	0.000754	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—POMC—autistic disorder	8.88e-05	0.000752	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL5—autistic disorder	8.82e-05	0.000746	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—POMC—autistic disorder	8.82e-05	0.000746	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—WNT2—autistic disorder	8.78e-05	0.000744	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL5—autistic disorder	8.76e-05	0.000741	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—WNT2—autistic disorder	8.72e-05	0.000738	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CALCA—autistic disorder	8.71e-05	0.000737	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GHR—autistic disorder	8.65e-05	0.000732	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CALCA—autistic disorder	8.65e-05	0.000732	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GHR—autistic disorder	8.59e-05	0.000727	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDE4A—autistic disorder	8.53e-05	0.000722	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—autistic disorder	8.48e-05	0.000718	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDE4A—autistic disorder	8.47e-05	0.000717	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—autistic disorder	8.37e-05	0.000708	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRB2—autistic disorder	8.04e-05	0.00068	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADRB2—autistic disorder	7.98e-05	0.000676	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AVPR1A—autistic disorder	7.93e-05	0.000671	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GRM5—autistic disorder	7.71e-05	0.000653	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VIP—autistic disorder	7.71e-05	0.000653	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GRM5—autistic disorder	7.66e-05	0.000648	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VIP—autistic disorder	7.66e-05	0.000648	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AVP—autistic disorder	7.55e-05	0.000639	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AVP—autistic disorder	7.5e-05	0.000635	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OXTR—autistic disorder	7.47e-05	0.000632	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OXTR—autistic disorder	7.42e-05	0.000628	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SCT—autistic disorder	7.39e-05	0.000626	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SCT—autistic disorder	7.34e-05	0.000621	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADRB2—autistic disorder	7.3e-05	0.000618	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRB2—autistic disorder	7.25e-05	0.000613	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	7.15e-05	0.000605	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADM—autistic disorder	7.05e-05	0.000597	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GABBR1—autistic disorder	7.05e-05	0.000597	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADM—autistic disorder	7e-05	0.000593	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GABBR1—autistic disorder	7e-05	0.000593	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EIF4E—autistic disorder	6.93e-05	0.000587	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EIF4E—autistic disorder	6.88e-05	0.000583	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDE4B—autistic disorder	6.87e-05	0.000582	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	6.87e-05	0.000582	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AVP—autistic disorder	6.86e-05	0.000581	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	6.84e-05	0.000579	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDE4B—autistic disorder	6.82e-05	0.000578	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AVP—autistic disorder	6.81e-05	0.000576	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OPRM1—autistic disorder	6.66e-05	0.000564	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OPRM1—autistic disorder	6.61e-05	0.000559	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PLA2G4A—autistic disorder	6.45e-05	0.000546	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PLA2G4A—autistic disorder	6.4e-05	0.000542	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	6.34e-05	0.000537	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR2A—autistic disorder	6.28e-05	0.000532	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR2A—autistic disorder	6.24e-05	0.000528	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GZMB—autistic disorder	6.09e-05	0.000515	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GZMB—autistic disorder	6.05e-05	0.000512	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—MAOB—autistic disorder	6.03e-05	0.00051	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR1B—autistic disorder	5.91e-05	0.0005	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OXT—autistic disorder	5.91e-05	0.0005	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR1B—autistic disorder	5.87e-05	0.000497	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OXT—autistic disorder	5.87e-05	0.000497	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR2A—autistic disorder	5.71e-05	0.000483	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR2A—autistic disorder	5.67e-05	0.00048	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PRKCB—autistic disorder	5.51e-05	0.000466	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TSC1—autistic disorder	5.5e-05	0.000465	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—DRD1—autistic disorder	5.5e-05	0.000465	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PRKCB—autistic disorder	5.47e-05	0.000463	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—DRD1—autistic disorder	5.46e-05	0.000462	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TSC1—autistic disorder	5.46e-05	0.000462	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NTRK2—autistic disorder	5.35e-05	0.000453	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—DRD3—autistic disorder	5.32e-05	0.000451	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NTRK2—autistic disorder	5.31e-05	0.000449	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—DRD3—autistic disorder	5.28e-05	0.000447	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CG—autistic disorder	5.27e-05	0.000446	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CG—autistic disorder	5.23e-05	0.000443	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL5—autistic disorder	5.21e-05	0.000441	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL5—autistic disorder	5.17e-05	0.000438	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CALCA—autistic disorder	5.15e-05	0.000436	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CALCA—autistic disorder	5.11e-05	0.000432	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	5.09e-05	0.000431	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—POMC—autistic disorder	5.02e-05	0.000425	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PRKCB—autistic disorder	5e-05	0.000423	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—POMC—autistic disorder	4.98e-05	0.000422	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PRKCB—autistic disorder	4.97e-05	0.00042	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CG—autistic disorder	4.79e-05	0.000405	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CG—autistic disorder	4.75e-05	0.000402	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—POMC—autistic disorder	4.56e-05	0.000386	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRL—autistic disorder	4.55e-05	0.000385	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—POMC—autistic disorder	4.52e-05	0.000383	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRL—autistic disorder	4.51e-05	0.000382	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRB2—autistic disorder	4.31e-05	0.000365	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRB2—autistic disorder	4.28e-05	0.000362	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	4.13e-05	0.00035	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AVP—autistic disorder	4.05e-05	0.000343	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF2—autistic disorder	4.03e-05	0.000341	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AVP—autistic disorder	4.02e-05	0.00034	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF2—autistic disorder	4e-05	0.000339	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLA2G4A—autistic disorder	3.81e-05	0.000322	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLA2G4A—autistic disorder	3.78e-05	0.00032	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IL2—autistic disorder	3.71e-05	0.000314	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MEF2C—autistic disorder	3.71e-05	0.000314	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL2—autistic disorder	3.68e-05	0.000312	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MEF2C—autistic disorder	3.68e-05	0.000311	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	3.65e-05	0.000309	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ITGB3—autistic disorder	3.61e-05	0.000306	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	3.6e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ITGB3—autistic disorder	3.59e-05	0.000303	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—COMT—autistic disorder	3.39e-05	0.000287	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTP1—autistic disorder	3.38e-05	0.000286	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2A—autistic disorder	3.37e-05	0.000285	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—MAOA—autistic disorder	3.37e-05	0.000285	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL2—autistic disorder	3.37e-05	0.000285	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	3.35e-05	0.000283	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2A—autistic disorder	3.35e-05	0.000283	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL2—autistic disorder	3.35e-05	0.000283	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	3.33e-05	0.000282	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TSC2—autistic disorder	3.2e-05	0.000271	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TSC2—autistic disorder	3.18e-05	0.000269	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—autistic disorder	3.13e-05	0.000265	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—autistic disorder	3.13e-05	0.000265	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—autistic disorder	3.11e-05	0.000263	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—autistic disorder	3.11e-05	0.000263	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—autistic disorder	3.1e-05	0.000263	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	3.06e-05	0.000259	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCB—autistic disorder	2.96e-05	0.00025	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCB—autistic disorder	2.93e-05	0.000248	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INPP1—autistic disorder	2.9e-05	0.000246	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACADSB—autistic disorder	2.9e-05	0.000246	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CG—autistic disorder	2.83e-05	0.000239	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APC—autistic disorder	2.83e-05	0.000239	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CG—autistic disorder	2.81e-05	0.000238	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APC—autistic disorder	2.81e-05	0.000238	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGF—autistic disorder	2.8e-05	0.000237	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGF—autistic disorder	2.78e-05	0.000235	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—POMC—autistic disorder	2.69e-05	0.000228	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—POMC—autistic disorder	2.67e-05	0.000226	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—autistic disorder	2.59e-05	0.000219	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—BTD—autistic disorder	2.59e-05	0.000219	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAPK1—autistic disorder	2.58e-05	0.000218	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—autistic disorder	2.57e-05	0.000218	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAPK1—autistic disorder	2.56e-05	0.000217	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—autistic disorder	2.46e-05	0.000208	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—autistic disorder	2.44e-05	0.000207	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TDO2—autistic disorder	2.2e-05	0.000186	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—POMC—autistic disorder	2.19e-05	0.000186	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HRAS—autistic disorder	2.07e-05	0.000175	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DHCR7—autistic disorder	2.07e-05	0.000175	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HRAS—autistic disorder	2.05e-05	0.000174	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL2—autistic disorder	1.99e-05	0.000168	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—autistic disorder	1.98e-05	0.000168	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL2—autistic disorder	1.98e-05	0.000167	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—autistic disorder	1.97e-05	0.000166	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—EXT1—autistic disorder	1.96e-05	0.000166	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC6A8—autistic disorder	1.96e-05	0.000166	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTEN—autistic disorder	1.87e-05	0.000159	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DAO—autistic disorder	1.87e-05	0.000158	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTEN—autistic disorder	1.86e-05	0.000157	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UPB1—autistic disorder	1.79e-05	0.000152	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM5—autistic disorder	1.67e-05	0.000141	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ASMT—autistic disorder	1.67e-05	0.000141	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC25A12—autistic disorder	1.57e-05	0.000133	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC19A1—autistic disorder	1.53e-05	0.000129	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK1—autistic disorder	1.52e-05	0.000129	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK1—autistic disorder	1.51e-05	0.000128	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADSL—autistic disorder	1.36e-05	0.000115	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—XDH—autistic disorder	1.33e-05	0.000113	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NPAS2—autistic disorder	1.31e-05	0.000111	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—STX1A—autistic disorder	1.31e-05	0.000111	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TCN2—autistic disorder	1.26e-05	0.000107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRAS—autistic disorder	1.22e-05	0.000103	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRAS—autistic disorder	1.21e-05	0.000103	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADA—autistic disorder	1.21e-05	0.000102	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—autistic disorder	1.17e-05	9.9e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—autistic disorder	1.16e-05	9.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—RORA—autistic disorder	1.1e-05	9.31e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MAOB—autistic disorder	1.03e-05	8.72e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TPH2—autistic disorder	9.58e-06	8.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DPYD—autistic disorder	9.42e-06	7.98e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CACNA1C—autistic disorder	8.76e-06	7.42e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DHFR—autistic disorder	7.97e-06	6.75e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP19A1—autistic disorder	6.24e-06	5.28e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—COMT—autistic disorder	5.8e-06	4.91e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTP1—autistic disorder	5.78e-06	4.89e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MAOA—autistic disorder	5.76e-06	4.88e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAT—autistic disorder	5.62e-06	4.76e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLA2G4A—autistic disorder	5.31e-06	4.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—autistic disorder	5.31e-06	4.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX1—autistic disorder	5.08e-06	4.3e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—autistic disorder	4.69e-06	3.97e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—autistic disorder	4.37e-06	3.7e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CG—autistic disorder	3.94e-06	3.34e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—POMC—autistic disorder	3.75e-06	3.18e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—autistic disorder	2.99e-06	2.53e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTEN—autistic disorder	2.61e-06	2.21e-05	CbGpPWpGaD
